Akoya Biosciences Future Growth
Future criteria checks 1/6
Akoya Biosciences is forecast to grow earnings and revenue by 52% and 14.5% per annum respectively. EPS is expected to grow by 55% per annum. Return on equity is forecast to be -92% in 3 years.
Key information
52.0%
Earnings growth rate
55.0%
EPS growth rate
| Life Sciences earnings growth | 16.9% |
| Revenue growth rate | 14.5% |
| Future return on equity | -92.0% |
| Analyst coverage | Good |
| Last updated | 14 May 2024 |
Recent future growth updates
Recent updates
Investors Continue Waiting On Sidelines For Akoya Biosciences, Inc. (NASDAQ:AKYA)
May 10
Is Akoya Biosciences (NASDAQ:AKYA) Weighed On By Its Debt Load?
Feb 28Investors Still Aren't Entirely Convinced By Akoya Biosciences, Inc.'s (NASDAQ:AKYA) Revenues Despite 31% Price Jump
Nov 25Akoya Biosciences Seeks Growth Despite Higher Operating Losses
May 30Akoya Biosciences, Inc. (NASDAQ:AKYA) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
May 11Akoya Biosciences and AstraZeneca ink collaboration agreement
Jun 04Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 158 | -15 | -3 | 3 | 5 |
| 12/31/2025 | 131 | -32 | -4 | 11 | 8 |
| 12/31/2024 | 108 | -52 | -30 | -14 | 6 |
| 3/31/2024 | 94 | -68 | -56 | -52 | N/A |
| 12/31/2023 | 97 | -63 | -55 | -51 | N/A |
| 9/30/2023 | 91 | -71 | -59 | -55 | N/A |
| 6/30/2023 | 85 | -76 | -61 | -54 | N/A |
| 3/31/2023 | 79 | -73 | -62 | -55 | N/A |
| 12/31/2022 | 75 | -71 | -61 | -53 | N/A |
| 9/30/2022 | 70 | -69 | -57 | -49 | N/A |
| 6/30/2022 | 64 | -63 | -57 | -51 | N/A |
| 3/31/2022 | 60 | -51 | -55 | -50 | N/A |
| 12/31/2021 | 55 | -44 | -41 | -36 | N/A |
| 9/30/2021 | 52 | -34 | -37 | -32 | N/A |
| 6/30/2021 | 48 | -28 | -24 | -21 | N/A |
| 3/31/2021 | 44 | -28 | -13 | -10 | N/A |
| 12/31/2020 | 42 | -22 | -10 | -7 | N/A |
| 12/31/2019 | 42 | -18 | -17 | -14 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: AKYA is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: AKYA is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: AKYA is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: AKYA's revenue (14.5% per year) is forecast to grow faster than the US market (8.4% per year).
High Growth Revenue: AKYA's revenue (14.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: AKYA is forecast to be unprofitable in 3 years.